Taken together, there might be a crosstalk between α7nAChR and E2, as well as ERs, to regulate the expression of each other, which is the basis for Ani to ameliorate hyperkalemia and decrease on-site mortality in CS. The gene discussed is CHRNA7; the disease is Cowden syndrome 1.